Cookies on this website

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies.

Continue Find out more

Shire Research and Development

We have an expertise in developing medicines for patients treated by specialist physicians, and for discovering new therapies for rare, life-threatening genetic disease. We look to acquire projects in later stages of development, offering lower risk for Shire and our investors, and offering increased possibility of getting medicines to market more quickly.  

Our Rare Disease business unit has leading-edge expertise in enzyme replacement therapy and a focus on developing treatments for other rare diseases.  This has allowed us to develop a number of effective treatments for conditions caused by enzyme or protein deficiencies. The human cell line technology platform is unique to Shire.


Key fact

We try to find new therapies
for rare and life-threatening